JPH0137636Y2 - - Google Patents
Info
- Publication number
- JPH0137636Y2 JPH0137636Y2 JP1979182732U JP18273279U JPH0137636Y2 JP H0137636 Y2 JPH0137636 Y2 JP H0137636Y2 JP 1979182732 U JP1979182732 U JP 1979182732U JP 18273279 U JP18273279 U JP 18273279U JP H0137636 Y2 JPH0137636 Y2 JP H0137636Y2
- Authority
- JP
- Japan
- Prior art keywords
- cover
- infusion
- infusion container
- container
- end opening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000001802 infusion Methods 0.000 claims description 106
- 239000007788 liquid Substances 0.000 claims description 18
- 239000000725 suspension Substances 0.000 claims description 16
- 229920002457 flexible plastic Polymers 0.000 claims description 14
- 239000003112 inhibitor Substances 0.000 claims description 14
- -1 polyethylene Polymers 0.000 description 18
- 239000004698 Polyethylene Substances 0.000 description 14
- 229920000573 polyethylene Polymers 0.000 description 14
- 229920006267 polyester film Polymers 0.000 description 11
- 235000016709 nutrition Nutrition 0.000 description 6
- 239000002985 plastic film Substances 0.000 description 6
- 239000003978 infusion fluid Substances 0.000 description 5
- 239000004743 Polypropylene Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 229920006284 nylon film Polymers 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- HJIAMFHSAAEUKR-UHFFFAOYSA-N (2-hydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC=C1C(=O)C1=CC=CC=C1 HJIAMFHSAAEUKR-UHFFFAOYSA-N 0.000 description 1
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000002960 lipid emulsion Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000021542 oral nutrition Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003902 salicylic acid esters Chemical class 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 210000001321 subclavian vein Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000002620 vena cava superior Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Description
【考案の詳細な説明】
考案の背景
技術分野
本考案は、波長290〜450nmの光線による分解
等の変質がおこりやすい輸液剤を充填した輸液バ
ツク等の透明容器に使用する輸液容器用カバーに
関する。[Detailed Description of the Invention] Background Technical Field of the Invention The present invention relates to a cover for an infusion container used for a transparent container such as an infusion bag filled with an infusion agent that is susceptible to decomposition or other deterioration due to light having a wavelength of 290 to 450 nm.
先行技術
従来、患者の生命の維持において、経口栄養、
経管栄養が不可能であつたり、あるいは不充分な
状態であつたり、または、それらが可能であつて
も患者の消化吸収機能が著しく不良であつたり、
更には食物が消化管を通過するのが原疾患の悪化
につながるような病態の場合には、栄養経静脈輸
液が行われることは公知であり、また容認されて
いる。Prior Art Traditionally, oral nutrition,
If tube feeding is not possible or is insufficient, or even if tube feeding is possible, the patient's digestive and absorption functions are extremely poor.
Furthermore, it is well known and accepted that intravenous nutritional infusions are performed in pathological conditions where passing food through the gastrointestinal tract aggravates the underlying disease.
経口に代り得る程の大量の栄養剤を血管を通し
て注入することを目的として栄養輸液療法は、レ
トリン（Wretlind）ら（アクタ・チルルジカ・
スカンジナビカ・サブリメント，278巻、３頁、
1961年）が大豆油を卵黄レシチンで乳化した脂肪
乳剤が無害に静注し得ることを見いだしたことに
始まり、デユードリツク（Dudrick）ら（サージ
エリ、64巻、134頁、1968年）が高濃度ブドウ糖
液を主栄養源とし、これにアミノ酸を配合して鎖
骨下静脈より上大静脈にシリコンラバーカテーテ
ルを刺通して投与し、臨床効果を得たことに基づ
いて発展した。 Nutrient infusion therapy, which aims to inject large amounts of nutrients through blood vessels to replace oral administration, was developed by Wretlind et al.
Scandinavica Subliment, Volume 278, Page 3,
(1961) found that a fat emulsion made by emulsifying soybean oil with egg yolk lecithin could be safely injected intravenously.Dudrick et al. (Surgieri, vol. 64, p. 134, 1968) It was developed based on the fact that clinical effects were obtained by administering a mixture of amino acids to the liquid as the main nutritional source through a silicone rubber catheter inserted into the superior vena cava from the subclavian vein.
輸液だけに頼つて一定期間生命を維持できる栄
養輸液剤の備えるべき条件は、生命に必要なすべ
ての栄養素、すなわち、ブドウ糖、アミノ酸、脂
肪、ビタミン、ミネラルを含むことが必要であ
る。 A nutritional infusion solution that can sustain life for a certain period of time by relying only on infusions must contain all the nutrients necessary for life, including glucose, amino acids, fats, vitamins, and minerals.
現状では、すべての栄養源を含む単一の輸液剤
は、波長290〜450nmの光線によるビタミンの分
解の問題などから製造されていない。 Currently, a single infusion solution containing all nutritional sources has not been manufactured due to problems such as the decomposition of vitamins by light with a wavelength of 290 to 450 nm.
栄養輸液療法を行うにあたつては、使用直前に
既存の輸液剤と病院の薬局製剤とから、さまざま
の栄養輸液剤を調剤している。いずれの処方にお
いてもブドウ糖が主栄養源となり、高濃度ブドウ
糖液がいわゆるベースソリユーシヨンとして用い
られ、これに用時電解質類、アミノ酸、ビタミ
ン、稀に脂肪乳剤が添加されて輸液に供されてい
る。 When performing nutritional infusion therapy, various nutritional infusions are prepared from existing infusions and hospital pharmacy preparations immediately before use. In both formulations, glucose is the main nutrient source, and a high-concentration glucose solution is used as the so-called base solution, to which electrolytes, amino acids, vitamins, and rarely fat emulsions are added before use for infusion. There is.
そして、この輸液においては、１入容器であ
れば約８時間２，３入容器であれば約24時間
輸注するなど、長時間室内に放置される。このた
め、この中でビタミン、特にビタミンＡ，B1お
よびビタミンＫは波長290〜450nmの光線により
輸液中に分解が進むことにより、輸液剤内容液か
らその成分が著しく失われ、かつ変質することが
確認されている。 This infusion solution is left indoors for a long period of time, such as approximately 8 hours for a single container and approximately 24 hours for a 2 or 3 container. For this reason, vitamins, especially vitamins A, B1 , and vitamin K, are decomposed during infusion by light with a wavelength of 290 to 450 nm, resulting in significant loss of their components from the infusion solution and deterioration in quality. has been confirmed.
ところが、実際に輸液を行う場合には、輸液バ
ツグ、輸液瓶などを波長290〜450nmの光線より
遮光しないで、そのまま用いて輸液を行うか、又
は、これらの容器をアルミホイル又は可視光線の
透過量の少ない色の濃いポリエチレンの袋で全体
を被包したり、容器の目盛りの部分だけを開けて
他の部分を波長290〜450nmの光線より遮光した
りして、輸液が行われている。 However, when actually administering an infusion, it is necessary to use an infusion bag, an infusion bottle, etc. as is without shielding it from light with a wavelength of 290 to 450 nm, or to wrap these containers in aluminum foil or a container that is transparent to visible light. Infusions are performed by encasing the entire container in a dark polyethylene bag with a small volume, or by opening only the graduated portion of the container and shielding the other portions from light with wavelengths of 290 to 450 nm.
従来技術の問題点
前述のように、輸液容器をそのまま用いて、波
長290〜450nmの光線を遮光しないで輸液する場
合には、ビタミンＡ，Ｂ、及びビタミンＫが長時
間の輸液中に受ける波長290〜450nmの光線の強
度及び線量に応じて分解され減少し、かつ輸液剤
の成分は変質するから、薬効が著しく低下し、当
初の処方目的を果たせない欠点がある。Problems with the Prior Art As mentioned above, when injecting an infusion using an infusion container as is and not blocking light with a wavelength of 290 to 450 nm, the wavelengths that vitamins A, B, and K are exposed to during long-term infusion It degrades and decreases depending on the intensity and dose of light in the range of 290 to 450 nm, and the components of the infusion solution change in quality, resulting in a significant drop in medicinal efficacy and failure to fulfill the original purpose of the prescription.
又、アルミホイル及び前述の色の濃いポリエチ
レン等の袋で被包した場合には、波長290〜
450nmの光線が遮光されることにより輸液中の輸
液剤の安定性は保たれるが、これらの遮光物質は
可視光線透過性を有しないために、輸液剤の液面
を確認できない欠点があり、又、このことより医
師、看護婦等の管理者にとつては輸液量の確認が
しにくいことおよび輸液を受ける患者に心理的不
安を与えていた。 In addition, when wrapped in aluminum foil or the aforementioned dark polyethylene bag, wavelengths of 290~
Although the stability of the infusion agent in the infusion is maintained by blocking 450 nm light, these light-shielding substances do not transmit visible light, so they have the disadvantage that the liquid level of the infusion agent cannot be confirmed. Additionally, this makes it difficult for administrators such as doctors and nurses to confirm the amount of infusion, and causes psychological anxiety to patients receiving infusions.
又、実際にアルミホイルやポリエチレン等の袋
を輸液バツグ等に被包する場合に、それらの型に
合わせて成形するのに手間がかかるという不便が
ある。 Furthermore, when actually enclosing a bag made of aluminum foil or polyethylene into an infusion bag or the like, there is an inconvenience in that it takes time and effort to mold the bag to fit the bag.
考案の目的
本考案の目的は、上記先行技術の問題点を解決
する輸液容器用カバーを提供することにある。Purpose of the invention The purpose of the present invention is to provide a cover for an infusion container that solves the problems of the prior art described above.
上記目的を達成するものは、上端に吊り下げ部
と下端に充填液排出口部を有する液体入り透明容
器のカバーにおいて、前記容器に係合するように
した上端係合部を有し、さらに、該カバーは、可
視光線透過性の可撓性プラスチツクに波長290〜
450nmの光線を遮断し、かつ可視光線を透過する
紫外線防止剤をコートしたものからなる輸液容器
用カバーである。 A cover for a liquid-filled transparent container having a hanging portion at the upper end and a filled liquid outlet portion at the lower end, which achieves the above object, further comprises: an upper end engaging portion adapted to engage with the container; The cover is made of flexible plastic that transmits visible light.
This is an infusion container cover coated with an ultraviolet inhibitor that blocks 450nm light and transmits visible light.
さらに、前記カバーは下端が、前記容器を収納
する下端開口部であり、前記上端係合部が、前記
容器の吊り下げ部に対応する上端開口部の両側に
位置していることが好ましい。 Furthermore, it is preferable that the lower end of the cover is a lower end opening for accommodating the container, and the upper end engaging portions are located on both sides of the upper end opening corresponding to the hanging portion of the container.
さらに、前記カバーが袋体であることが好まし
く、特に袋体が、偏平状であり、かつ上端開口部
が偏平面からみて、略Ｗ字型であることが好まし
い。さらに、前記上端係合部は液体入り透明容器
の補助懸垂孔と対応する位置に懸垂孔を有するこ
とが好ましい。 Furthermore, it is preferable that the cover is a bag, and it is particularly preferable that the bag has a flat shape, and the upper end opening is approximately W-shaped when viewed from the flat surface. Furthermore, it is preferable that the upper end engaging portion has a suspension hole at a position corresponding to an auxiliary suspension hole of the transparent liquid-filled container.
さらに、前記カバーは、２枚の可撓性プラスチ
ツク間に紫外線防止剤層を有するものであること
が好ましい。 Furthermore, the cover preferably has a UV inhibitor layer between two pieces of flexible plastic.
考案の具体的説明
本考案の輸液容器用カバーは、上端に吊り下げ
部と下端に充填液排出口を有する液体入り透明容
器に用いる輸液容器用カバーである。上記吊り下
げ部は通常、該透明容器の上端の硬質プラスチツ
ク部分に開口を設けることにより形成されている
ものである。Specific Description of the Invention The infusion container cover of the present invention is used for a transparent liquid-filled container that has a hanging portion at the upper end and a filled liquid discharge port at the lower end. The hanging portion is usually formed by providing an opening in the hard plastic portion at the upper end of the transparent container.
以下、本考案の輸液容器用カバーを図面に基づ
き説明する。 Hereinafter, the infusion container cover of the present invention will be explained based on the drawings.
第１図に示すように、輸液容器用カバー１は、
下端に輸液容器を収納するための下端開口部２を
有している。そして、輸液容器用カバー１は、輸
液容器に係合する上端係合部４，４を有してい
る。また上部に輸液容器の吊り下げ部に対応する
上端開口部３を有していることが好ましく、さら
に前記上端係合部４，４は、該上端開口部３の両
側にあることが好ましい。上記上端開口部３を設
けるならば、輸液容器用カバーを付けたままで輸
液容器を吊り下げて輸液を行うことが容易であ
る。 As shown in FIG. 1, the infusion container cover 1 includes:
It has a lower end opening 2 for accommodating an infusion container at the lower end. The infusion container cover 1 has upper end engaging portions 4, 4 that engage with the infusion container. Further, it is preferable that the upper end has an upper end opening 3 corresponding to a hanging part of the infusion container, and furthermore, it is preferable that the upper end engaging parts 4, 4 are on both sides of the upper end opening 3. If the upper end opening 3 is provided, it is easy to suspend the infusion container and perform infusion with the infusion container cover attached.
また、本考案のカバーは、可視光線透過性の可
撓性プラスチツクに波長290〜450nmの光線を遮
断し、かつ可視光線を透過する紫外線防止剤をコ
ートしたものからなり、袋体であることが好まし
い。 In addition, the cover of the present invention is made of flexible plastic that transmits visible light and is coated with an ultraviolet inhibitor that blocks light in the wavelength range of 290 to 450 nm and transmits visible light, and can be in the form of a bag. preferable.
本考案の具体的実施態様としては、後述する通
りであるが、必ずしもこれらのものに限定される
ものではない。 Specific embodiments of the present invention will be described later, but the invention is not necessarily limited to these.
まず、本考案の実施態様としては、上記輸液容
器用カバー１は、袋体が偏平状で、かつ上端開口
部３が偏平面からみて略Ｗ字型のものが望まし
い。 First, as an embodiment of the present invention, it is desirable that the infusion container cover 1 has a flat bag body and an upper end opening 3 that is approximately W-shaped when viewed from the flat surface.
即ち、本考案の輸液容器用カバー１は実際に輸
液容器を収納するときには、袋体が柔軟にふくら
み容易に該容器を収納しうる。 That is, when the cover 1 for an infusion container of the present invention actually stores an infusion container, the bag body flexibly inflates and can easily store the container.
また、上端開口部３の中央部には対称形に形成
された閉鎖用突片７，７が設けられており、該閉
鎖用突片７，７はまず該閉鎖用突片７，７の１片
を輸液容器の吊り下げ部８の中を通して袋体の内
側に折り曲げた後、他方の１片を該吊り下げ部８
の中を通して先に折り曲げた１片の上に重なり合
わせて折り曲げて、上端開口部３を閉鎖できるよ
うに、該吊り下げ部８の幅とほぼ同一の幅を有
し、かつ該吊り下げ部８の中を通して折り込んで
上下に重なり合わせるのに十分な長さを有してい
る。 In addition, symmetrically formed closing protrusions 7, 7 are provided at the center of the upper end opening 3, and the closing protrusions 7, 7 are first connected to one of the closing protrusions 7, 7. After passing one piece through the hanging part 8 of the infusion container and bending it inside the bag, the other piece is inserted into the hanging part 8.
The hanging part 8 has a width substantially the same as the width of the hanging part 8 so that the upper end opening 3 can be closed by folding it over the top of the previously folded piece. It is long enough to be folded through the inside and stacked one above the other.
更に、本考案の輸液容器用カバー１は、輸液容
器の補助懸垂孔５，５と対応する位置に懸垂孔
６，６を有するものであれば、更に好適である。
すなわち、このような輸液容器用カバー１は第１
図のように輸液容器の補助懸垂孔５，５を使用し
て、該容器を吊り下げて輸液を行う場合にも、輸
液容器用カバーを被つたままで輸液を行うことが
できる。 Furthermore, it is more preferable that the infusion container cover 1 of the present invention has suspension holes 6, 6 at positions corresponding to the auxiliary suspension holes 5, 5 of the infusion container.
That is, such an infusion container cover 1 has a first
Even when infusing the container by suspending it using the auxiliary suspension holes 5, 5 of the infusion container as shown in the figure, the infusion can be performed with the infusion container cover covered.
また、上記にそれぞれ記載した本考案の輸液容
器用カバー１は、ポリエステルフイルム層紫外線
防止剤層ポリエチレンフイルム層の三層より成る
可撓性プラスチツク製フイルムよりなるものが望
ましい。 The infusion container cover 1 of the present invention described above is preferably made of a flexible plastic film consisting of three layers: a polyester film layer, an ultraviolet ray inhibitor layer, and a polyethylene film layer.
すなわち、本考案の輸液容器用カバー１は、た
とえばポリエステルフイルムにヒドロキシベンゾ
フエノン、ベンゾトリアゾール、サリチル酸エス
テル等無色の紫外線防止剤をコートし、そのコー
ナ面にポリエチレンフイルムをラミネート加工し
た可撓性プラスチツク製フイルムより成る。 That is, the infusion container cover 1 of the present invention is made of a flexible plastic made of, for example, a polyester film coated with a colorless ultraviolet inhibitor such as hydroxybenzophenone, benzotriazole, or salicylic acid ester, and a polyethylene film laminated on the corner surface. It consists of a manufactured film.
このほか、ポリエステルフイルムとポリエチレ
ンフイルムの組み合わせ以外には、ポリエステル
フイルムとポリエステルフイルム、ポリエチレン
フイルムとポリエチレンフイルム、ポリプロピレ
ンフイルムとポリエステルフイルム、ポリプロピ
レンフイルムとポリプロピレンフイルム、ポリプ
ロピレンフイルムとナイロンフイルム、ポリエス
テルフイルムとナイロンフイルム、ナイロンフイ
ルムとナイロンフイルム等を用いた、間に紫外線
防止剤層を有する三層より成る可撓性プラスチツ
ク製フイルムでもよい。 In addition to the combination of polyester film and polyethylene film, there are other combinations such as polyester film and polyester film, polyethylene film and polyethylene film, polypropylene film and polyester film, polypropylene film and polypropylene film, polypropylene film and nylon film, polyester film and nylon film, A flexible plastic film consisting of three layers, such as nylon film and nylon film, having an ultraviolet inhibitor layer between them may also be used.
次に本考案の輸液容器用カバーの製造方法につ
いて説明する。 Next, a method of manufacturing the infusion container cover of the present invention will be explained.
まず、波長290〜450nmの光線を遮断し、かつ
可視光線透過性の可撓性プラスチツク製フイルム
のシート材を準備する。次に、一対のシート材を
半分に折り曲げて両側を熱融着し、下端を開放さ
せて開口を有する偏平状の袋体を形成する。次い
で、開口部と対向する上端部の中央部に、輸液容
器の吊り下げ部と対応する部分を打ち抜き等の手
段によつて切り抜いて、上端開口部を設ける。該
上端開口部は、輸液容器用カバーを被つたときに
輸液容器の吊り下げ部が露出するように十分な大
きさをもたせて形成する。又、略Ｗ字型の上端開
口部又は懸垂孔を有する本考案の輸液容器用カバ
ーを製造するときには、同様に上記方法により得
られた下端に開口を有する偏平状の袋体の上端部
に、打ち抜き等により略Ｗ字型の上端開口部又は
懸垂孔を設けて製造する。 First, a sheet of flexible plastic film that blocks light with a wavelength of 290 to 450 nm and transmits visible light is prepared. Next, the pair of sheet materials is folded in half and both sides are heat-sealed, and the lower end is opened to form a flat bag having an opening. Next, an upper end opening is provided at the center of the upper end facing the opening by cutting out a portion corresponding to the hanging portion of the infusion container using means such as punching. The upper end opening is formed to have a sufficient size so that the hanging portion of the infusion container is exposed when the infusion container cover is covered. Furthermore, when manufacturing the infusion container cover of the present invention having a substantially W-shaped upper end opening or hanging hole, the upper end of a flat bag having an opening at the lower end similarly obtained by the above method, Manufactured by punching or the like to provide a substantially W-shaped upper end opening or suspension hole.
尚、本考案の輸液容器用カバーの実施例として
は第１図に示すように次のようなものが望まし
い。 As an embodiment of the infusion container cover of the present invention, as shown in FIG. 1, the following is preferable.
すなわち、下端に設けられた下端開口部２と上
部に設けられた偏平面からみて略Ｗ字型を有する
上端開口部３と、該上端開口部３の両側に設けら
れた上端係合部４，４と、該上端開口部３の中央
部に対称形に形成された閉鎖用突片７，７と、懸
垂孔６，６とから成る輸液容器用カバーである。 That is, a lower end opening 2 provided at the lower end, an upper end opening 3 provided at the upper part and having a substantially W-shape when viewed from the flat surface, and upper end engaging parts 4 provided on both sides of the upper end opening 3. 4, closing protrusions 7, 7 formed symmetrically in the center of the upper end opening 3, and suspension holes 6, 6.
上記輸液容器用カバーは、さらに上端開口部３
が輸液容器を収納するために片手を入れるに十分
な大きさを有し、閉鎖用突片７，７が輸液容器の
吊り下げ部８とほぼ同一の幅を有し、かつ該吊り
下げ部８の中を通して前述のように折り曲げるに
十分な長さを有するものであり、かつ袋体がポリ
エステルフイルムとポリエチレンフイルムの間に
紫外線防止剤層を有する三層の可撓性プラスチツ
ク製フイルムより成り、熱融着等の加工適性をよ
くするため袋体の内側である第三層にポリエチレ
ンフイルムがくるようにしたものである。 The above-mentioned infusion container cover further has an upper end opening 3.
is large enough to accommodate one hand in order to accommodate the infusion container, the closing protrusions 7, 7 have approximately the same width as the hanging portion 8 of the infusion container, and the hanging portion 8 The bag is long enough to be passed through the inside and folded as described above, and the bag body is made of a three-layer flexible plastic film with a UV inhibitor layer between a polyester film and a polyethylene film, and is heat-resistant. In order to improve suitability for processing such as fusion, a polyethylene film is placed on the third layer, which is the inside of the bag.
考案の具体的作用
本考案の輸液容器用カバーを使用するにあたつ
ては、まず上端開口部３より片手を挿入しもう一
方の手で輸液容器を下端開口部２より挿入し収納
した後、本考案の輸液容器用カバーを被つたまま
で輸液容器を吊り下げて輸液を行う。本考案の輸
液容器用カバーは、波長290〜450nmの光線を遮
断し、かつ可視光線透過性の可撓性プラスチツク
製袋体からなるから、波長290〜450nmの光線を
遮断し、かつ輸液残量の確認ができる。Specific Effects of the Invention When using the infusion container cover of the present invention, first insert one hand into the upper end opening 3, insert the infusion container with the other hand through the lower end opening 2, and then store it. Infusion is carried out by hanging the infusion container while covering it with the infusion container cover of the present invention. The infusion container cover of the present invention blocks light in the wavelength range of 290 to 450 nm and is made of a flexible plastic bag that is transparent to visible light. can be confirmed.
又、上端開口部３の中央部に閉鎖用突片７，７
を設けた本考案の輸液容器用カバーを使用する場
合は、まず該閉鎖用突片７，７の１片を輸液容器
の吊り下げ部８の中を通して袋体の内側に折り曲
げた後、他方の１片を該吊り下げ部８の中を通し
て先に折り曲げた１片の上に重なり合わせて折り
曲げて上端開口部３を閉鎖した後、輸液容器を吊
り下げて輸液を行う。 In addition, closing protrusions 7, 7 are provided at the center of the upper end opening 3.
When using the infusion container cover of the present invention, first pass one of the closing protrusions 7 through the hanging part 8 of the infusion container and bend it inside the bag body, and then fold the other one. One piece is passed through the hanging portion 8 and folded to overlap the previously bent piece to close the upper end opening 3, and then the infusion container is hung to perform infusion.
この場合、上端開口部３から入る波長290〜
450nmの光線は上述のように閉鎖用突片７，７を
重なり合わせて該開口部３を閉鎖することにより
遮断される。 In this case, the wavelength entering from the upper end opening 3 is 290~
The 450 nm light beam is blocked by overlapping the closing protrusions 7, 7 to close the opening 3 as described above.
又、輸液容器が補助懸垂孔５，５を有する本考
案の輸液容器用カバーを使用する場合は、それと
対応する位置に設けられた本考案の輸液容器用カ
バーの懸垂孔６，６を該補助懸垂孔５，５と重な
り合うように位置させて、吊り下げ用ハンガー１
０に吊り下げて輸液を行う。更に、ポリエステル
フイルム、紫外線防止剤及びポリエチレンフイル
ムの三層より成る本考案の輸液容器用カバーにお
いては、波長290〜540nmの光線は第１層である
ポリエステルフイルム層は透過するが、第２層の
紫外線防止剤層により吸着され、第３層のポリエ
チレン層には透過されないので、内容液は波長
290〜450nmの光線より保護されるが、可視光線
は外層の第１層のポリエステル層、第２層の紫外
線防止剤層、第３層のポリエチレン層の全層で、
全体としては0.01〜0.1ｍ／ｍ厚の当該可撓性プ
ラスチツク製フイルム（望ましくは、0.05ｍ／ｍ
厚のものが用いられる）を透過するから、波長
290〜450nmの光線を遮遮断し、かつ内容液の残
存量の確認で可能である。 In addition, when the infusion container uses the infusion container cover of the present invention having the auxiliary suspension holes 5, 5, the infusion container cover of the present invention provided at the corresponding position is connected to the auxiliary suspension holes 6, 6 of the infusion container cover of the present invention. Place the hanging hanger 1 so that it overlaps with the hanging holes 5, 5.
Suspend the tube at 0 and perform infusion. Furthermore, in the infusion container cover of the present invention, which is composed of three layers of a polyester film, an ultraviolet ray inhibitor, and a polyethylene film, light with a wavelength of 290 to 540 nm is transmitted through the first polyester film layer, but is transmitted through the second layer. It is adsorbed by the UV inhibitor layer and does not pass through the third polyethylene layer, so the content liquid
It is protected from light rays of 290 to 450 nm, but visible light is protected by all layers: the first polyester outer layer, the second ultraviolet inhibitor layer, and the third polyethylene layer.
The flexible plastic film has a total thickness of 0.01 to 0.1 m/m (preferably 0.05 m/m
(thick ones are used), so the wavelength
This can be done by blocking light from 290 to 450 nm and checking the remaining amount of the liquid inside.
考案の具体的効果
本考案の輸液容器用カバーは、上端に吊り下げ
部と下端に充填液排出口部を有する液体入り透明
容器のカバーにおいて、前記容器に係合するよう
にした上端係合部を有し、さらに、該カバーは、
可視光線透過性の可撓性プラスチツクに波長290
〜450nmの光線を遮断し、かつ可視光線を透過す
る紫外線防止剤をコートしたものからなるので、
本考案の輸液容器用カバーを被つたままで該容器
を吊り下げて輸液を行うことができ、調剤済み内
容液を波長290〜450nmの光線より保護し、該光
線による内容液成分の分解による内容液の変質お
よびそれによる薬効低下を防止することができ
る。Specific Effects of the Invention The infusion container cover of the present invention is a cover for a liquid-filled transparent container that has a hanging portion at the upper end and a filled liquid discharge port at the lower end, and has an upper end engaging portion that engages with the container. Further, the cover has:
Visible light transparent flexible plastic with wavelength 290
It is coated with an ultraviolet inhibitor that blocks light of ~450 nm and transmits visible light.
Infusions can be performed by hanging the container with the infusion container cover of the present invention covered, and the dispensed contents are protected from light rays with a wavelength of 290 to 450 nm, and the contents are decomposed by the light rays. It is possible to prevent deterioration of the liquid and the resulting decrease in drug efficacy.
又、本考案の輸液容器用カバーは可視光線透過
性であるから、輸液容器の内容液残量を確認する
ことが可能であり、内容液残量の確認ができない
ことから生ずる医師、看護婦等の管理者にとつて
の輸液量の確認がしにくいことの不便さ、および
患者に与える心理的不安を解消するものである。 In addition, since the infusion container cover of the present invention is transparent to visible light, it is possible to check the amount of liquid remaining in the infusion container, and doctors, nurses, etc. This eliminates the inconvenience of having difficulty confirming the volume of infusion for administrators, and the psychological anxiety caused to patients.
次に、輸液容器の吊り下げ部に対応して設けら
れた上端開口部３の中央部に閉鎖用突片７，７を
設けた上述の本考案の輸液容器用カバーにおいて
は、該閉鎖用突片７，７を相互に輸液容器の開口
部８を通して折り曲げて、上下に重なり合わせて
上端開口部３を閉鎖して輸液を行うことにより、
本考案の輸液容器用カバーを被つたまま輸液容器
を吊り下げて輸液を行う場合に、上端開口部３よ
り入る波長290〜450nmの光線を遮断できるから、
さらに効果的に内容液を該光線より保護すること
ができる。 Next, in the above-mentioned infusion container cover of the present invention, in which the closing protrusions 7, 7 are provided in the center of the upper end opening 3 provided corresponding to the hanging part of the infusion container, the closing protrusions 7, 7 are provided. By folding the pieces 7, 7 together through the opening 8 of the infusion container, overlapping them vertically, and closing the upper end opening 3 to perform infusion,
When injecting an infusion by hanging the infusion container with the infusion container cover of the present invention covered, it is possible to block light rays with a wavelength of 290 to 450 nm entering from the upper opening 3.
Furthermore, the liquid content can be more effectively protected from the light rays.
又、輸液容器の補助懸垂孔５，５に対応して懸
垂孔６，６を設けた上述の本考案の輸液容器用カ
バーにおいては、該補助懸垂孔５，５を使用して
輸液容器を吊り下げて輸液を行う場合にも、本考
案の輸液容器用カバーを被つたままで吊り下げて
輸液を行うことが可能である。 In addition, in the above-mentioned infusion container cover of the present invention in which the suspension holes 6, 6 are provided corresponding to the auxiliary suspension holes 5, 5 of the infusion container, the auxiliary suspension holes 5, 5 are used to suspend the infusion container. Even when performing infusion by hanging the infusion container cover of the present invention, it is possible to perform infusion by suspending the infusion container cover of the present invention.
さらに、ポリエステルフイルム、紫外線防止
剤、ポリエチレンフイルムの三層を有する可撓性
のプラスチツク製フイルムより成る上述の本考案
の輸液容器用カバーにおいては、波長290〜
450nmの光線を遮断し、かつ内容液の確認が可能
であり、又、輸液容器を容易に収納する操作性に
富むなど、さまざまの利点を有する。 Furthermore, in the above-mentioned infusion container cover of the present invention, which is made of a flexible plastic film having three layers of a polyester film, an ultraviolet inhibitor, and a polyethylene film, wavelengths of 290~
It has various advantages such as being able to block 450nm light, allowing confirmation of the liquid content, and being highly operable to easily store infusion containers.
第１図は本考案の一実施例としての輸液容器に
装着させた輸液容器用カバーの使用例を示す斜視
図。
１……輸液容器用カバー、２……下端開口部、
３……上端開口部、４……上端係合部、５……輸
液容器補助懸垂孔、６……懸垂孔、７……閉鎖用
突片、８……輸液容器吊り下げ部、９……輸液容
器、１０……吊り下げ用ハンガー。
FIG. 1 is a perspective view showing an example of use of an infusion container cover attached to an infusion container as an embodiment of the present invention. 1... Infusion container cover, 2... Lower end opening,
3... Upper end opening, 4... Upper end engaging part, 5... Infusion container auxiliary suspension hole, 6... Suspension hole, 7... Closing protrusion, 8... Infusion container hanging part, 9... Infusion container, 10...Hanger for hanging.
Claims (1)
有する液体入り透明容器のカバーにおいて、前
記容器に係合するようにした上端係合部を有
し、さらに、該カバーは、可視光線透過性の可
撓性プラスチツクに波長290〜450nmの光線を
遮断し、かつ可視光線を透過する紫外線防止剤
をコートしたものからなることを特徴とする輸
液容器用カバー。 (2) 前記カバーは下端が、前記容器を収納する下
端開口部であり、前記上端係合部が、前記容器
の吊り下げ部に対応する上端開口部の両側に位
置している実用新案登録請求の範囲第１項記載
の輸液容器用カバー。 (3) 前記カバーが、袋体である実用新案登録請求
の範囲第１項または第２項記載の輸液容器用カ
バー。 (4) 前記袋体が、偏平状であり、かつ上端開口部
が偏平面からみて、略Ｗ字型である実用新案登
録請求の範囲第３項記載の輸液容器用カバー。 (5) 前記上端係合部は、液体入り透明容器の補助
懸垂孔と対応する位置に懸垂孔を有している実
用新案登録請求の範囲第１項ないし第４項記載
の輸液容器用カバー。 (6) 前記カバーは、２枚の可撓性プラスチツク間
に紫外線防止剤層を有するものである実用新案
登録請求の範囲第１項ないし第５項記載の輸液
容器用カバー。[Claims for Utility Model Registration] (1) A cover for a liquid-filled transparent container having a hanging portion at the upper end and a filled liquid outlet portion at the lower end, the cover having an upper end engaging portion that engages with the container. Further, the cover is made of a flexible plastic that transmits visible light and is coated with an ultraviolet inhibitor that blocks light in the wavelength range of 290 to 450 nm and transmits visible light. cover. (2) The lower end of the cover is a lower end opening for storing the container, and the upper end engaging portions are located on both sides of the upper end opening corresponding to the hanging portion of the container. A cover for an infusion container according to item 1. (3) The cover for an infusion container according to claim 1 or 2, wherein the cover is a bag. (4) The cover for an infusion container according to claim 3, wherein the bag has a flat shape, and the upper end opening is approximately W-shaped when viewed from the flat surface. (5) The cover for an infusion container according to any one of claims 1 to 4, wherein the upper end engaging portion has a suspension hole at a position corresponding to an auxiliary suspension hole of the transparent liquid-filled container. (6) The cover for an infusion container according to any of claims 1 to 5, which is a registered utility model, wherein the cover has an ultraviolet inhibitor layer between two sheets of flexible plastic.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1979182732U JPH0137636Y2 (en) | 1979-12-28 | 1979-12-28 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1979182732U JPH0137636Y2 (en) | 1979-12-28 | 1979-12-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS56101345U JPS56101345U (en) | 1981-08-10 |
| JPH0137636Y2 true JPH0137636Y2 (en) | 1989-11-13 |
Family
ID=29693056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1979182732U Expired JPH0137636Y2 (en) | 1979-12-28 | 1979-12-28 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0137636Y2 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011000333A (en) * | 2009-06-19 | 2011-01-06 | Terumo Corp | Package housing container filled with medicine |
| JP2013144574A (en) * | 2011-12-12 | 2013-07-25 | Toppan Printing Co Ltd | Pouch |
| JP2013237485A (en) * | 2012-05-17 | 2013-11-28 | Toppan Printing Co Ltd | Pouch |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5298125A (en) * | 1976-02-13 | 1977-08-17 | Nippon Carbide Kogyo Kk | Cultivation of farm crop |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5465597U (en) * | 1977-10-18 | 1979-05-09 |
-
1979
- 1979-12-28 JP JP1979182732U patent/JPH0137636Y2/ja not_active Expired
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5298125A (en) * | 1976-02-13 | 1977-08-17 | Nippon Carbide Kogyo Kk | Cultivation of farm crop |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011000333A (en) * | 2009-06-19 | 2011-01-06 | Terumo Corp | Package housing container filled with medicine |
| JP2013144574A (en) * | 2011-12-12 | 2013-07-25 | Toppan Printing Co Ltd | Pouch |
| JP2013237485A (en) * | 2012-05-17 | 2013-11-28 | Toppan Printing Co Ltd | Pouch |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS56101345U (en) | 1981-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3921804A (en) | Medication dispensing package | |
| KR100299630B1 (en) | Multi Chamber Container | |
| EP2702976B1 (en) | Container for administering medication | |
| Wåhlin-Boll et al. | Bioavailability, pharmacokinetics and effects of glipizide in type 2 diabetics | |
| WO1993012730A1 (en) | Safety packaging improvements | |
| JPH0228334B2 (en) | ||
| AU8915291A (en) | System for creating at a site, remote from a sterile environment, a parenteral solution | |
| Anderson et al. | Reconstitution of hematin for intravenous infusion | |
| CA2528159C (en) | Aseptic combination preparation | |
| JPH0137636Y2 (en) | ||
| JPS6330432Y2 (en) | ||
| WO2015190416A1 (en) | Transfusion bag/bottle storage bag, method for using same, and method for producing same | |
| JPH03111053A (en) | Medical container | |
| Davey | Current practices for home enteral nutrition | |
| JP2592416B2 (en) | Medical container | |
| JPH05111526A (en) | Medicinal container | |
| CA2350644C (en) | Blind clinical trial device | |
| JPH0380024B2 (en) | ||
| CN209871059U (en) | Storing box convenient to hemodialysis patient uses | |
| JPH048910Y2 (en) | ||
| CN213312429U (en) | Integrated light-shading infusion apparatus | |
| JP4476598B2 (en) | Multi-chamber infusion container and multi-chamber infusion container with drug | |
| Tandberg | How to treat and prevent drug toxicity | |
| JP2017056091A (en) | Bag for liquid nutritional supplement | |
| JPS587399Y2 (en) | label |